She Jun, Jiang Jinjun, Ye Ling, Hu Lijuan, Bai Chunxue, Song Yuanlin
Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, 180 Feng Lin Road, Shanghai, 200032, China.
Clin Transl Med. 2020 Feb 20;9(1):19. doi: 10.1186/s40169-020-00271-z.
An ongoing outbreak of 2019-nCoV pneumonia was first identified in Wuhan, Hubei province, China at the end of 2019. With the spread of the new coronavirus accelerating, person-to-person transmission in family homes or hospitals, and intercity spread of 2019-nCoV occurred. At least 40,261 cases confirmed, 23,589 cases suspected, 909 cases death and 3444 cases cured in China and worldwide 24 countries confirmed 383 cases being diagnosed, 1 case death in February 10th, 2020. At present, the mortality of 2019-nCoV in China is 2.3%, compared with 9.6% of SARS and 34.4% of MERS reported by WHO. It seems the new virus is not as fatal as many people thought. Chinese authorities improved surveillance network, made the laboratory be able to recognize the outbreak within a few weeks and announced the virus genome that provide efficient epidemiological control. More comprehensive information is required to understand 2019-nCoV feature, the epidemiology of origin and spreading, and the clinical phenomina. According to the current status, blocking transmission, isolation, protection, and alternative medication are the urgent management strategies against 2019-nCoV.
2019年新型冠状病毒肺炎疫情于2019年底首先在中国湖北省武汉市被发现。随着新型冠状病毒传播加速,家庭或医院内出现人际传播,且该病毒出现跨城市传播。截至2020年2月10日,中国境内至少确诊40261例,疑似23589例,死亡909例,治愈3444例;全球24个国家共确诊383例,死亡1例。目前,中国2019年新型冠状病毒的死亡率为2.3%,相比之下,世界卫生组织报告的非典死亡率为9.6%,中东呼吸综合征死亡率为34.4%。看来这种新型病毒并不像许多人认为的那样致命。中国当局加强了监测网络,使实验室能够在几周内识别出疫情,并公布了病毒基因组,以实施有效的流行病学防控。需要更全面的信息来了解2019年新型冠状病毒的特征、起源和传播的流行病学情况以及临床现象。根据目前的情况,阻断传播、隔离、防护和替代药物治疗是应对2019年新型冠状病毒的紧急管理策略。